Case Studies

Global WL Remediation Plan Development

PROBLEM STATEMENT Client: A large renowned compliance consulting company needed a principal consultant to develop a multi-site holistic remediation plan for warning letters (WL) remediation. EXPERTISE AND SOLUTIONS The client company hired a principal consultant from...

read more

PAI Readiness for Virtual Company

PROBLEM STATEMENT Client: A renowned large consulting company (client) needed a Principal consultant to get a virtual company ready for Pre-approval inspection (PAI). The virtual company was manufacturing ophthalmic API and Drug products and was getting ready for an...

read more

Regulatory Assessment

Problem Statement Client: A law firm was working on litigation issues for vaccine products. The client needed an analytical and Quality expert to conduct a regulatory assessment of product-related issues and provide an assessment report, including a deposition....

read more

Site PAI Readiness

Problem Statement Client 1: One of the sites of a large Pharma company producing ophthalmic products (solutions and suspensions) was getting ready for Health Canada Pre-Approval Inspection (PAI) and hired a consulting company to prepare for PAI. Client 2: One of the...

read more

Lab Equipment Qualification

Problem Statement Client: Our client was a large global biopharmaceutical company and was working on different work streams of consent decree remediations. Our client needed someone to lead the remediation effort for the new Quality Control Lab Qualification and work...

read more

Due-Diligence Assessment

Problem Statement Client: An investment company was interested in making an investment decision for a Biopharmaceutical company and needed quality assessment to understand regulatory compliance risks associated with the company’s product portfolio and the several...

read more

Quality Management for Early-Stage Virtual Company

Problem Statement Client 1: An early-stage virtual (discovery stage) pharmaceutical company, developing novel small molecule drug candidates needed the Quality unit to support the IND enabling and Phase 1 studies. The company did not have a quality unit in place. All...

read more